Meningeal and cortical grey matter pathology in multiple sclerosis

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Gh Popescu, Bogdan F ^a,b   Lucchinetti, Claudia F ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Saskatoon City Hospital   (Canada)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN CORTEX; CELL POPULATION; CEREBELLUM; COGNITIVE DEFECT; DEMYELINATION; EPILEPSY; GLIA; GRAY MATTER; HIPPOCAMPUS; HUMAN; LEUKOCYTE; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; REVIEW; WHITE MATTER;

EID: 84859100978     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-11     Document Type: Review

References (57)

1. Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 1992, 31(3):333-336. 10.1002/ana.410310317, 1637140.
2. Charcot JM. Lecture VI. Disseminated Sclerosis. Pathological Anatomy. Lectures on the Diseases of the Nervous System 1887, 157-181. London: The New Sydenham Society.
3. Sobel RA, Moore GRW. Demyelinating diseases. Greenfield's Neuropathology. Volume 2, 8th edition 2008, 1513-1608. Oxford University Press, Love S, Louis DN, Ellison DW.
4. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001, 50(3):389-400. 10.1002/ana.1123, 11558796.
5. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962, 25:315-320. 10.1136/jnnp.25.4.315, 495470, 14016083.
6. Lumsden CE. The neuropathology of multiple sclerosis. Multiple sclerosis and other demyelinating diseases. Volume 9 1970, North Holland, Vinken PJ, Bruyn GW. Amsterdam.
7. Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004, 63(1):89-93.
8. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Current opinion in neurology 2002, 15(3):239-245. 10.1097/00019052-200206000-00003, 12045719.
9. Lazeron RH, Langdon DW, Filippi M, van Waesberghe JH, Stevenson VL, Boringa JB, Origgi D, Thompson AJ, Falautano M, Polman CH, et al. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR. Mult Scler 2000, 6(4):280-285.
10. Moriarty DM, Blackshaw AJ, Talbot PR, Griffiths HL, Snowden JS, Hillier VF, Capener S, Laitt RD, Jackson A. Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images. AJNR Am J Neuroradiol 1999, 20(10):1956-1962.
11. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991, 41(5):685-691.
12. Rovaris M, Filippi M, Minicucci L, Iannucci G, Santuccio G, Possa F, Comi G. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000, 21(2):402-408.
13. Sokic DV, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M, Peric V, Dragutinovic G, Levic Z. Seizures in multiple sclerosis. Epilepsia 2001, 42(1):72-79.
14. Spatt J, Chaix R, Mamoli B. Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol 2001, 248(1):2-9. 10.1007/s004150170262, 11266015.
15. Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003, 9(4):323-331. 10.1191/1352458503ms917oa, 12926836.
16. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003, 62(7):723-732.
17. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999, 122(Pt 1):17-26.
18. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128(Pt 11):2705-2712.
19. Richert ND, Ostuni JL, Bash CN, Duyn JH, McFarland HF, Frank JA. Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b. AJNR Am J Neuroradiol 1998, 19(9):1705-1713.
20. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006, 67(6):960-967. 10.1212/01.wnl.0000237551.26858.39, 17000961.
21. Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Wolfgang B, Parisi JE, Scheithauer BW, Giannini C, et al. Inflammatory Cortical Demyelination in Early Multiple Sclerosis. N Engl J Med 2011, 365(23):2188-2197. 10.1056/NEJMoa1100648, 22150037.
22. Duvernoy HM, Risold PY. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev 2007, 56(1):119-147. 10.1016/j.brainresrev.2007.06.002, 17659349.
23. Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F, Witter MP, Huitinga I, van der Valk P. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007, 66(9):819-827. 10.1097/nen.0b013e3181461f54, 17805012.
24. Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001, 60(12):1208-1218.
25. Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Bruck W, Rauschka H, Schmidbauer M, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007, 17(1):38-44. 10.1111/j.1750-3639.2006.00041.x, 17493036.
26. Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, Reynolds R. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2009, 19(2):238-253. 10.1111/j.1750-3639.2008.00177.x, 18492094.
27. Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti CF. A case of multiple sclerosis presenting with inflammatory cortical demyelination. Neurology 2011, 76(20):1705-1710. 10.1212/WNL.0b013e31821a44f1, 21576686.
28. Bunyan RF, Popescu BF, Carter JL, Caselli RJ, Parisi JE, Lucchinetti CF. Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Arch Neurol 2011, 68(4):525-528. 10.1001/archneurol.2011.50, 21482934.
29. Gilmore CP, Donaldson I, Bo L, Owens T, Lowe J, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009, 80(2):182-187. 10.1136/jnnp.2008.148767, 18829630.
30. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005, 64(12):1101-1107. 10.1097/01.jnen.0000190067.20935.42, 16319720.
31. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130(Pt 4):1089-1104.
32. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004, 14(2):164-174. 10.1111/j.1750-3639.2004.tb00049.x, 15193029.
33. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007, 204(12):2899-2912. 10.1084/jem.20071030, 2118531, 17984305.
34. Torkildsen O, Stansberg C, Angelskar SM, Kooi EJ, Geurts JJ, van der Valk P, Myhr KM, Steen VM, Bo L. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 2010, 20(4):720-729.
35. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Bruck W, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009, 132(Pt 12):3318-3328. 2792367, 19638446.
36. Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, Serafini B, Aloisi F, Roncaroli F, Magliozzi R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011, 134(Pt 9):2755-2771.
37. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002, 52(5):650-653. 10.1002/ana.10326, 12402265.
38. Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N. A Wallerian degeneration pattern in patients at risk for MS. Neurology 2000, 54(5):1155-1160.
39. Bo L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007, 64(1):76-80. 10.1001/archneur.64.1.76, 17210812.
40. Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, Castelijns JA. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 2006, 23(5):628-636. 10.1002/jmri.20564, 16565955.
41. Calabrese M, Gallo P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 2009, 15(8):933-941. 10.1177/1352458509106510, 19667021.
42. De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003, 60(7):1157-1162.
43. Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Morra A, Rinaldi L, Romualdi C, Perini P, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007, 64(10):1416-1422. 10.1001/archneur.64.10.1416, 17923625.
44. Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009, 66(9):1144-1150. 10.1001/archneurol.2009.174, 19752305.
45. Calabrese M, Grossi P, Favaretto A, Romualdi C, Atzori M, Rinaldi F, Perini P, Saladini M, Gallo P. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J Neurol Neurosurg Psychiatry 2011,
46. Sharma R, Narayana PA, Wolinsky JS. Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 2001, 7(4):221-226.
47. Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti C. A Case of Multiple Sclerosis Presenting with Inflammatory Cortical Demyelination. Neurology 2011, 76(20):1705-10. 10.1212/WNL.0b013e31821a44f1, 21576686.
48. Merkler D, Ernsting T, Kerschensteiner M, Bruck W, Stadelmann C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 2006, 129(Pt 8):1972-1983.
49. Albert M, Antel J, Bruck W, Stadelmann C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 2007, 17(2):129-138. 10.1111/j.1750-3639.2006.00043.x, 17388943.
50. Brown DA, Sawchenko PE. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol 2007, 502(2):236-260. 10.1002/cne.21307, 17348011.
51. Lassmann H, Wisniewski HM. Chronic relapsing EAE. Time course of neurological symptoms and pathology. Acta Neuropathol 1978, 43(1-2):35-42. 10.1007/BF00684996, 676685.
52. Weller RO, Engelhardt B, Phillips MJ. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol 1996, 6(3):275-288. 10.1111/j.1750-3639.1996.tb00855.x, 8864284.
53. Calabrese M, Filippi M, Gallo P. Cortical lesions in multiple sclerosis. Nature reviews Neurology 2010, 6(8):438-444. 10.1038/nrneurol.2010.93, 20625376.
54. Filippi M, Rocca MA. Novel MRI approaches to assess patients with multiple sclerosis. Current opinion in neurology 2010, 23(3):212-217. 10.1097/WCO.0b013e32833787b0, 20164769.
55. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008, 7(9):841-851. 10.1016/S1474-4422(08)70191-1, 18703006.
56. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007, 68(9):634-642. 10.1212/01.wnl.0000250267.85698.7a, 17325269.
57. Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 2010, 133(Pt 3):858-867.